Check Cap Ltd (NASDAQ:CHEK)’s share price dropped 25.7% during mid-day trading on Monday . The company traded as low as $2.21 and last traded at $2.25, with a volume of 1,357,053 shares changing hands. The stock had previously closed at $3.03.

CHEK has been the topic of a number of recent research reports. Zacks Investment Research raised shares of Check Cap from a “hold” rating to a “buy” rating and set a $1.50 price objective on the stock in a research note on Tuesday, June 14th. Maxim Group reiterated a “buy” rating on shares of Check Cap in a report on Thursday, May 26th. Finally, Chardan Capital cut their target price on shares of Check Cap from $6.00 to $4.00 and set a “buy” rating on the stock in a report on Friday, May 20th.

The stock’s market cap is $29.21 million. The firm has a 50 day moving average of $1.45 and a 200-day moving average of $2.24.

Check-Cap Ltd. (Check-Cap) is a clinical-stage medical diagnostics company. The Company is engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The Company’s system consists of main components, such as ingestible scanning capsule; Capsule Positioning System (CPS), a recorder worn on the patient’s back, and a personal computer (PC)-based work station for data reconstruction and image processing.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.